Literature DB >> 11941004

Clinical Features and Predictors of Postictal Excitement.

D. P. Devanand1, Kathleen M. Briscoe, Harold A. Sackeim.   

Abstract

In a retrospective case control study, clinical features of postictal excitement following electroconvulsive therapy (ECT) were examined in 24 patients and 24 matched controls. The two groups did not differ in clinical outcome, degree of pretreatment agitation, anesthetic or succinylcholine dose, number of ECTs received, mean seizure duration, number of titrated treatments with subconvulsive stimulation, or type of EEG ending. Patients who became excited early in the treatment course rarely manifested this phenomenon at all subsequent treatments. Within the "excited" group, a minority of patients became excited following the first ECT, and only 34.3% of their treatments resulted in postictal excitement. It may not be necessary to routinely use postseizure benzodiazepines in patients who have once exhibited a postictal excitement.

Entities:  

Year:  1989        PMID: 11941004

Source DB:  PubMed          Journal:  Convuls Ther        ISSN: 0749-8055


  5 in total

1.  [Vagus nerve stimulation, repetitive transcranial magnetic stimulation, and electroconvulsive therapy in the treatment of depressive disorders].

Authors:  M Bajbouj; I Heuser
Journal:  Nervenarzt       Date:  2005-01       Impact factor: 1.214

2.  Delayed Onset and Prolonged ECT-Related Delirium.

Authors:  Sameer Hassamal; Ananda Pandurangi; Vasu Venkatachalam; James Levenson
Journal:  Case Rep Psychiatry       Date:  2013-09-03

3.  Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia.

Authors:  Suna Su Aksay; Jan Malte Bumb; Dmitry Remennik; Manfred Thiel; Laura Kranaster; Alexander Sartorius; Christoph Janke
Journal:  Neuropsychiatr Dis Treat       Date:  2017-05-23       Impact factor: 2.570

4.  Prevalence and Predictors of Postictal Confusion After Electroconvulsive Therapy.

Authors:  Pichai Ittasakul; Phathamon Jarernrat; Phern-Chern Tor
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-02       Impact factor: 2.570

5.  Cognitive Impairment and Electroconvulsive Therapy in Geriatric Depression, What Could be the Role of Rivastigmine? A Case Series.

Authors:  Audrey Monica van Schaik; Didi Rhebergen; Marieke Jantien Henstra; Daniel J Kadouch; Eric van Exel; Maximilianus Lourentius Stek
Journal:  Clin Pract       Date:  2015-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.